Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Post Info TOPIC: Roche and Ascletis announce collaboration to develop danoprevir in China


Guru

Status: Offline
Posts: 5627
Date:
Roche and Ascletis announce collaboration to develop danoprevir in China
Permalink  
 


Basel, Switzerland and Shanghai, China - 15 April 2013

Roche and Ascletis enter collaboration to advance treatment options for Chinese patients with Hepatitis C

Roche and Ascletis announced today that they have entered into a collaboration to develop and commercialize Roche`s investigational drug danoprevir in China for the treatment of Hepatitis-C Virus (HCV).

It is estimated that over 10 million patients in China are chronically infected with HCV.  The majority of these are genotype 1b, which has proven highly responsive to danoprevir.   Roche and Ascletis are joining forces to develop a therapy with the potential to address a serious public health problem and to provide an effective new treatment option for Chinese patients with HCV.

Danoprevir is an experimental HCV protease inhibitor.

Link to media release...

http://www.roche.com/media/media_releases/med-cor-2013-04-15.html

 

 



__________________

Jill 

(71 yo, lives in UK)

Was Gen 3a, 

24wks Peg Ifn/Riba, Sep 2010 - Mch 2011

UND @ Wk.4, UND @ EOT, 

SVR Nov 2011 --> Still UND @ EOT + 4 yrs.

 

 

Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.

Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.